Six-time Olympic cycling champion Sir Chris Hoy shares his experience living with stage 4 prostate cancer, advocating for better screening and raising funds for research while navigating his own health challenges and family life.
Dermot Murnaghan, a veteran TV presenter known for his work on BBC, ITV, and Sky News, has died at the age of 68. He passed away peacefully at home in North London, a year after revealing his stage four prostate cancer diagnosis. Murnaghan was an advocate for men's health, urging them to get tested for prostate cancer.
Dermot Murnaghan, a veteran BBC and Sky News presenter known for hosting "Eggheads", has died at the age of 68. His family announced his passing, stating he died peacefully at home in north London after a period of illness with prostate cancer. Murnaghan publicly shared his stage four prostate cancer diagnosis last year.
Dermot Murnaghan, a veteran TV presenter known for his work on BBC, ITV, and Sky News, has died at the age of 68. He had been diagnosed with stage four prostate cancer a year ago and was an advocate for early testing.
Hong Kong researchers are developing an affordable blood test for prostate cancer, aiming to reduce the need for invasive biopsies. The technology is expected to launch in about two years, offering a less uncomfortable diagnostic process for patients like Peter Wan, who experienced a lengthy and invasive journey to his diagnosis.
Jeremy Clarkson announced he is in remission from prostate cancer, days after revealing his diagnosis. The TV presenter shared on Clarkson's Farm that he had an aggressive form diagnosed in 2025, but follow-up tests confirmed he is cancer-free.
Jeremy Clarkson, the renowned British presenter, has revealed he has been diagnosed with aggressive but early-stage prostate cancer. He announced the news during the latest episode of his Amazon Prime Video series, 'Clarkson's Farm,' stating he has known since May and underwent surgery, with the outcome still uncertain.
A large-scale study from Harvard University suggests that men ejaculating over 21 times per month may have a 19-22% lower risk of developing low-risk prostate cancer. However, frequent ejaculation showed no significant protective effect against high-risk or metastatic prostate cancer. Urologist Huang Po-jen emphasizes that this is an observational study showing correlation, not causation, and advises against deliberately altering ejaculation frequency for cancer prevention. He recommends a healthy lifestyle and regular screenings as the primary methods for prostate cancer prevention.
Thousands of men in England diagnosed with low- or intermediate-risk prostate cancer will be offered SABR, a precision radiotherapy that reduces treatment sessions from 20 to five. This advanced technique targets the disease more effectively, minimizing side effects and allowing patients to return to normal life sooner. NHS England expects all 48 radiotherapy centers to offer the treatment within weeks.
UK health secretary backs UKNSC recommendation against population-wide PSA screening, opting for targeted testing of high-risk BRCA2 mutation carriers. Funding is increased for the Transform trial to include more Black men, addressing concerns about health inequalities.
Tens of thousands more black men aged 45-74 in the UK will be invited for prostate cancer checks as part of an £18 million government-funded trial. The move aims to find better testing methods for the disease, which disproportionately affects black men.
Cancer claims 10 million lives annually, with varying deadliness. New drugs show promise for pancreatic and head/neck cancers, and precision medicine is advancing. However, a global shortfall of 100 million healthcare workers by 2050 and treatment delays are critical issues. Worryingly, cancer rates are rising in those under 50, linked to environmental factors.
UK's National Screening Committee recommends prostate cancer screening via PSA blood test only for men with BRCA2 gene variant and family history of specific cancers, citing harms outweighing benefits in other groups.
A 71-year-old man in Taiwan was diagnosed with stage II prostate cancer and opted for the non-invasive 'HIFU knife' treatment. The procedure, which uses focused ultrasound to destroy cancer cells, resulted in a quick recovery with preserved urinary and sexual function, significantly improving his quality of life.
A comprehensive review of six trials with nearly 800,000 men shows prostate cancer screening reduces deaths by 2 per 1,000 men screened, but also leads to unnecessary treatments and complications, highlighting the need for informed patient decisions.
Israeli Prime Minister Benjamin Netanyahu announced he underwent treatment for early-stage prostate cancer, revealing he delayed publishing the diagnosis for two months during the war with Iran to avoid what he called false propaganda. The tumor was found at a very early stage with no metastases and has been fully treated, according to Hadassah Hospital oncology chief. The 76-year-old leader previously had surgery for an enlarged benign prostate in 2024.
Former Brighton and Newcastle manager Chris Hughton has revealed he was diagnosed with prostate cancer in April last year. The cancer was detected early and he underwent successful surgery in May. The 67-year-old told the Daily Mail that the news didn't scare him, saying his first impression was that he'd be fine. During his playing career, Hughton was a full-back who made 398 appearances for Tottenham, winning a UEFA Cup and two FA Cups in the early 1980s, and earned 53 caps for the Republic of Ireland.
BBC Radio 2 presenter Bob Harris has announced his prostate cancer has spread to his upper spine. The Country Show host, who has presented on the station since 1999, spent two weeks in hospital undergoing radiotherapy and is now home on the pathway to recovery, hoping to return to his shows in May.
